Filing Details

Accession Number:
0001192482-19-000405
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-13 16:32:40
Reporting Period:
2019-11-08
Accepted Time:
2019-11-13 16:32:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267565 Collegium Pharmaceutical Inc COLL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640701 B Alison Fleming C/O Collegium Pharmaceutical, Inc.
100 Technology Center Drive
Stoughton MA 02072
Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-08 25,000 $5.73 98,556 No 4 M Direct
Common Stock Disposition 2019-11-08 25,000 $19.44 73,556 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Purchase) Disposition 2019-11-08 25,000 $0.00 25,000 $5.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
35,378 2025-03-19 No 4 M Direct
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.71, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The option was fully vested and exercisable as of November 8, 2019.